Vascular Graft Market Research by Raw Material (Polyester Grafts, EPTFE Grafts, Polyurethane Grafts, Biosynthetic Grafts), Indication (Endovascular Aneurysm Repair, Peripheral Vascular Repair, Hemodialysis Access), End-user (Hospitals, Ambulatory Surgical Centers), and Region- Forecast till 2030

Vascular Graft Market Overview

Vascular Graft Market is expected grow USD 5,956.93 Million at a CAGR 7.15% during the forecast 2020-2030, says market research future (MRFR). A vascular graft or vascular bypass is a surgical operation that is used to bypass a damaged artery by rerouting blood from one area of normal blood flow to another area of reasonably normal blood flow. There are numerous vascular grafts available depending on the indication and the raw materials utilized to construct the graft. Vascular grafts are used to provide access for hemodialysis and to repair aneurysms including thoracic aneurysms endovascularly.

The high frequency of abdominal aneurysms, the growing geriatric population, and the rising prevalence of smoking and other risk factors for aneurysms are the primary reasons driving this market's expansion. The global vascular grafts market is primarily driven by an increase in the prevalence of vascular diseases such as atherosclerosis, pulmonary embolism, deep vein thrombosis, and other cardiac disorders, as well as an increase in the number of hospitals and surgery centers, which facilitates disease diagnosis and treatment.

Additionally, developments in vascular disease devices are expected to add to the market's growth. Additionally, new product introductions contribute to the market's growth. However, during the projected period, product failures and recalls are expected to restrain market growth.

Major Market Key Players

Notable players of vascular graft market comprise Cardinal Health (US), Gore Medical (US), Terumo (Japan), C. R. Bard (US), Medtronic (Ireland), LeMaitre Vascular (US), B. Braun Melsugen AG (Germany), Endologix (US), Maquet (Germany), and Cook Medical (US).

Segmentation Analysis

The global vascular graft market has been segmented on the basis of raw material, indication, end-user, and region.

Based on raw material, the global vascular graft market has been segmented into polyester grafts, EPTFE grafts, polyurethane grafts, and biosynthetic grafts. While polyester grafts hold the major market share among all the segments, biosynthetic graft is considered to be the fastest growing segment.

Based on indication, the global vascular graft market has been segmented into endovascular aneurysm repair, peripheral vascular repair, and hemodialysis access. Endovascular aneurysm repair is considered to be the major segment among all the segments. The peripheral vascular repair segment is expected to be the fastest growing segment.

Based on end-user, the global vascular graft market has been segmented into hospitals and ambulatory surgical centers. Among these, the hospitals hold the major segment and are anticipated to maintain its dominance during the review period. The ambulatory surgical centers are the fastest growing segment across the globe.

Regional Analysis

The global vascular graft market span across four major regions, namely Americas, Europe, Asia-Pacific, and Middle East & Africa.

America dominates the global vascular graft market and is anticipated to maintain its dominance over the assessment period. The growth is attributed to the high prevalence of cardiovascular diseases, diabetes, and chronic kidney diseases. With the availability of state-of-the-art healthcare infrastructure and presence of reimbursement coverage, the market is set to flourish. Asia Pacific is presumed to register the fastest market growth owing to the growing prevalence of diabetes and cardiovascular diseases in this region. Also improving healthcare infrastructure and epidemiological transition which has resulted in high rate of premature death is anticipated to trigger the demand for minimally invasive grafting procedures.

Recent Development

March 2022: Cue Health Inc., a healthcare technology firm, and Cardinal Health, a global leader in the vascular graft industry, today announced the expansion of distribution of Cue's COVID-19 tests for professional usage and over-the-counter use. Cardinal Health was chosen as one of Cue's key distributors because to its demonstrated expertise in assisting in the commercialization of diagnostic technology. Cardinal Health serves almost 90% of US hospitals and over 60,000 pharmacies. This agreement will assist Cue's breakthrough nucleic acid amplification test (NAAT) expand its reach into both traditional and non-traditional healthcare settings. Cardinal Health is trusted by customers across the country to deliver high-quality laboratory goods, and Cue shares their aim of putting diagnostic information at the heart of care.

Vascular Graft Market by Raw Material

• Polyester Grafts


• EPTFE Grafts


• Polyurethane Grafts


• Biosynthetic Grafts

Vascular Graft Market by Indication

• Endovascular Aneurysm Repair


• Peripheral Vascular Repair


• Hemodialysis Access

Vascular Graft Market by End User

• Hospitals


• Ambulatory Surgical Centers

Vascular Graft Market by Region

• Americas


• Europe


• Asia Pacific


• Middle East & Africa

Research Methodology

Data analysts at Market Research Future ensure objective analysis of the market while preparing market research reports by engaging set of standards which allow a comprehensive view of the market and its several components. Several factors comprising economic growth, government expenditure, supply channels and distribution channels have been scrutinized effort to relay precise information. Also, market-size estimation and validation use top-down and bottom-up approaches in order to obtain data from the demand and supply side. Analysis of data have been performed by using research framework suited to the specific industry. The frameworks are developed by the MRFR team which serves as a research standard that provides tools to create dependable market reports.

Report Scope:

Report Attribute/Metric	Details
Market Size	2030: USD 5956.93 Billion
CAGR	7.15% CAGR (2020-2030)
Base Year	2019
Forecast Period	2020-2030
Historical Data	2018
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Raw material, Indication, End-user
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Cardinal Health (US), Gore Medical (US), Terumo (Japan), C. R. Bard (US), Medtronic (Ireland), LeMaitre Vascular (US), B. Braun Melsugen AG (Germany), Endologix (US), Maquet (Germany), and Cook Medical (US).
Key Market Opportunities	High treatment cost Complications related to prosthetic grafts
Key Market Drivers	Increasing prevalence of cardiac diseases, end-stage renal diseases Growing prevalence of diabetes, coronary artery diseases, cardiac aneurysms, and hypertension

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :